Effect of Intravenous FerRic carbOxymaltose oN Reverse Remodeling Following Cardiac Resynchronization Therapy

NCT03380520 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Ferric Carboxymaltose
DRUG: Placebo

Sponsor

Hasselt University

Collaborators

[object Object]